Literature DB >> 20724121

[Infant botulism in France, 1991-2009].

L-A King1, M-R Popoff, C Mazuet, E Espié, V Vaillant, H de Valk.   

Abstract

Infant botulism is caused by the ingestion of spores of Clostridium botulinum and affects newborns and infants under 12 months of age. Ingested spores multiply and produce botulinum toxin in the digestive tract, which then induces clinical symptoms. A single French case was described in the literature prior to 1991. We describe the cases of infant botulism identified in France between 1991 and 2009. All clinical suspicions of botulism must be declared in France. Biological confirmation of the disease is provided by the National reference laboratory for anaerobic bacteria and botulism at the Pasteur Institute. During this period, 7 cases of infant botulism were identified, 1 per year from 2004 to 2008 and 2 in 2009. The median age of affected infants was 119 days and all were female. All infants presented with constipation and oculomotor symptoms. All were hospitalized and required mechanical ventilation. The infants recovered from their botulism. The diagnosis of infant botulism was biologically confirmed for all patients. One 4-month-old infant was treated with a single dose of the human-derived botulism antitoxin specific for infant botulism types A and B (BabyBIG®). The infants all had different feeding habits ranging from exclusive breast feeding to a mix of formula feeding and solid food consumption. The consumption of honey, the only documented risk food for this disease, was reported for 3 of the infants. The honey had been placed on the pacifier of 2 infants and directly in the mouth of the 3rd by the mother. Infant botulism, a form of botulism that was previously rarely recognized in France, has been reported more frequently during the last 6 years. This disease remains rare but nonetheless severe. In light of recent epidemiological data, efforts to raise awareness among parents of infants and health professionals on the danger of infant botulism and particularly, its association with honey consumption seems necessary.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724121     DOI: 10.1016/j.arcped.2010.06.010

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  9 in total

1.  Two cases of type A infant botulism in Grenoble, France: no honey for infants.

Authors:  Gautier Hoarau; Isabelle Pelloux; Armelle Gayot; Isabelle Wroblewski; Michel-Robert Popoff; Christelle Mazuet; Max Maurin; Jacques Croizé
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

Review 2.  Recent Developments in Botulinum Neurotoxins Detection.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Microorganisms       Date:  2022-05-10

Review 3.  Perspective: Novel Commercial Packaging and Devices for Complementary Feeding.

Authors:  Melissa Ann Theurich
Journal:  Adv Nutr       Date:  2018-09-01       Impact factor: 8.701

Review 4.  Human Botulism in France, 1875-2016.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

5.  Contribution of Foods and Poor Food-Handling Practices to the Burden of Foodborne Infectious Diseases in France.

Authors:  Jean-Christophe Augustin; Pauline Kooh; Thomas Bayeux; Laurent Guillier; Thierry Meyer; Nathalie Jourdan-Da Silva; Isabelle Villena; Moez Sanaa; Olivier Cerf
Journal:  Foods       Date:  2020-11-11

Review 6.  Antibiotic, pesticide, and microbial contaminants of honey: human health hazards.

Authors:  Noori Al-Waili; Khelod Salom; Ahmed Al-Ghamdi; Mohammad Javed Ansari
Journal:  ScientificWorldJournal       Date:  2012-10-14

7.  Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins.

Authors:  E B Shelley; D O'Rourke; K Grant; E McArdle; L Capra; A Clarke; E McNamara; R Cunney; P McKeown; C F L Amar; C Cosgrove; M Fitzgerald; P Harrington; P Garvey; F Grainger; J Griffin; B J Lynch; G McGrane; J Murphy; N Ni Shuibhne; J Prosser
Journal:  Epidemiol Infect       Date:  2014-10-13       Impact factor: 4.434

8.  Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Authors:  Christelle Mazuet; Christine Legeay; Jean Sautereau; Laurence Ma; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  Genome Biol Evol       Date:  2016-06-13       Impact factor: 3.416

Review 9.  Toxemia in Human Naturally Acquired Botulism.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.